Cargando…

Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study

Compliance is a key factor in the maintenance treatment of bipolar disorder. This noninterventional study was conducted to explore factors associated with higher levels of compliance in bipolar patients, all treated in routine clinical settings. Bipolar outpatients (Clinical Global Impression of Sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutzelnigg, Alexandra, Kopeinig, Martin, Chen, Chih-Ken, Fábián, Ágnes, Pujol-Luna, María Gloria, Shin, Young-chul, Treuer, Tamás, D’yachkova, Yulia, Deix, Claudia, Kasper, Siegfried, Doby, Dagmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206769/ https://www.ncbi.nlm.nih.gov/pubmed/25360398 http://dx.doi.org/10.1186/s40345-014-0013-x

Ejemplares similares

Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis
por: Peuskens, Joseph, et al.
Publicado: (2012)

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
por: Xue, Hai Bo Haber, et al.
Publicado: (2014)

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study
por: Bitter, Istvan, et al.
Publicado: (2010)

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
por: Novick, Diego, et al.
Publicado: (2017)

The potential role of appetite in predicting weight changes during treatment with olanzapine
por: Case, Michael, et al.
Publicado: (2010)

An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report
por: Hobbs, David, et al.
Publicado: (2013)

Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
por: Montgomery, William, et al.
Publicado: (2012)

Review of olanzapine in the management of bipolar disorders
por: Narasimhan, Meera, et al.
Publicado: (2007)

Improvement of the noradrenergic symptom cluster following treatment with milnacipran
por: Kasper, Siegfried, et al.
Publicado: (2011)

Olanzapine Discontinuation Emergent Recurrence in Bipolar Disorder
por: Arora, Manu, et al.
Publicado: (2014)

Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France
por: Nagar, Saurabh P., et al.
Publicado: (2018)

Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
por: Montgomery, William, et al.
Publicado: (2015)

Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties
por: Zhao, Jingping, et al.
Publicado: (2014)

Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
por: Ye, Wenyu, et al.
Publicado: (2014)

Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France
por: Mytelka, Daniel S., et al.
Publicado: (2018)

Olanzapine induced tardive dystonia in case of adolescent bipolar disorder
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2009)

Epidemiology of Adult Soft-Tissue Sarcomas in Germany
por: Saltus, Catherine W., et al.
Publicado: (2018)

Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
por: Molife, Cliff, et al.
Publicado: (2023)

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation
por: Anand, Ernie, et al.
Publicado: (2015)

Delirium Associated with Olanzapine Therapy in an Elderly Male with Bipolar Affective Disorder
por: Sharma, Ravi C., et al.
Publicado: (2010)

Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration
por: Zain, Mohd Aizat, et al.
Publicado: (2012)

Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study design
por: Lal, Rohit, et al.
Publicado: (2013)

Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
por: Sahoo, Manoj Kumar, et al.
Publicado: (2017)

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
por: Montgomery, William, et al.
Publicado: (2014)

Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study
por: Pan, Pei-Yin, et al.
Publicado: (2014)

Effect Of Risperidone And Olanzapine On The Metabolic Profile Of Drug Naïve Bipolar Disorder Patients.
por: Gupta, Gajal, et al.
Publicado: (2022)

Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States
por: Zuluaga-Sanchez, Santiago, et al.
Publicado: (2018)

Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group
por: Xu, Lei, et al.
Publicado: (2015)

Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination
por: Walker, Daniel J., et al.
Publicado: (2017)

Comparison of 1- and 2-year screening intervals for women undergoing screening mammography
por: Wai, E S, et al.
Publicado: (2005)

How May Ramucirumab Help Improve Treatment Outcome for Patients with Gastrointestinal Cancers?
por: Chen, Ming-Huang, et al.
Publicado: (2021)

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
por: Kishi, Taro, et al.
Publicado: (2019)

Comparison of Mental Health Resources Used by Patients With Bipolar Disorder Treated With Risperidone, Olanzapine, or Quetiapine
por: Gianfrancesco, Frank, et al.
Publicado: (2005)

Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine
por: Fornaro, Michele
Publicado: (2010)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao, Keming, et al.
Publicado: (2013)

Pharmacovigilance on olanzapine
por: Lingeswaran, Anand, et al.
Publicado: (2010)

Teratogenicity with Olanzapine
por: Prakash, Sathya, et al.
Publicado: (2014)

Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study
por: Novick, Diego, et al.
Publicado: (2015)

Therapeutic compliance of bipolar women during the perinatal period
por: Andrea, B.
Publicado: (2023)

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
por: García-Cabeza, Ignacio, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_tp9tfftjsrghid52ceqd8ki4qb